- Home
- SPRC vs APVO Comparison
SPRC vs APVO Comparison
Compare SPRC & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRC
- APVO
- Stock Information
- Founded
- SPRC 2004
- APVO 2016
- Country
- SPRC Israel
- APVO United States
- Employees
- SPRC N/A
- APVO N/A
- Industry
- SPRC Biotechnology: Pharmaceutical Preparations
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- SPRC Health Care
- APVO Health Care
- Exchange
- SPRC Nasdaq
- APVO Nasdaq
- Market Cap
- SPRC 1.2M
- APVO 1.2M
- IPO Year
- SPRC N/A
- APVO N/A
- Fundamental
- Price
- SPRC $0.31
- APVO $0.33
- Analyst Decision
- SPRC
- APVO
- Analyst Count
- SPRC 0
- APVO 0
- Target Price
- SPRC N/A
- APVO N/A
- AVG Volume (30 Days)
- SPRC 2.8M
- APVO 259.7K
- Earning Date
- SPRC 09-27-2024
- APVO 11-12-2024
- Dividend Yield
- SPRC N/A
- APVO N/A
- EPS Growth
- SPRC N/A
- APVO N/A
- EPS
- SPRC N/A
- APVO N/A
- Revenue
- SPRC $2,879,000.00
- APVO N/A
- Revenue This Year
- SPRC N/A
- APVO N/A
- Revenue Next Year
- SPRC N/A
- APVO N/A
- P/E Ratio
- SPRC N/A
- APVO N/A
- Revenue Growth
- SPRC 113.73
- APVO N/A
- 52 Week Low
- SPRC $0.28
- APVO $0.29
- 52 Week High
- SPRC $14.22
- APVO $21.56
- Technical
- Relative Strength Index (RSI)
- SPRC 38.57
- APVO 44.28
- Support Level
- SPRC $0.28
- APVO $0.32
- Resistance Level
- SPRC $0.32
- APVO $0.37
- Average True Range (ATR)
- SPRC 0.03
- APVO 0.02
- MACD
- SPRC 0.00
- APVO 0.00
- Stochastic Oscillator
- SPRC 20.67
- APVO 40.34
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.